1. Bioinformatic analyses reveal the key pathways and genes in the CXCR4 mediated mesenchymal subtype of glioblastoma.
- Author
-
Yi, Li, Tong, Luqing, Li, Tao, Hai, Long, Abeysekera, Iruni Roshanie, Tao, Zhennan, Ma, Haiwen, Liu, Peidong, Xie, Yang, Li, Jiabo, Yuan, Feng, Yu, Shengping, and Yang, Xuejun
- Subjects
GLIOBLASTOMA multiforme ,BIOINFORMATICS ,MESENCHYMAL stem cells ,GENETIC overexpression - Abstract
Glioblastoma multiforme (GBM) is one of the most lethal types of tumour, despite severe treatment methods. The Cancer Genome Atlas has categorised GBMs into proneural, neural, classical and mesenchymal subtypes; the mesenchymal subgroup has the worst prognosis. CXCR4 has been reported as selectively overexpressed in the mesenchymal subtype and positively associated with MES markers. However, to the best of our knowledge the underlying mechanisms regarding how CXCR4 may regulate mesenchymal GBM are still unknown. The present study aimed to investigate the critical pathways mediated by CXCR4 in mesenchymal GBM using bioinformatic analyses. The results suggested that CXCR4 is a predictor of poor prognosis and may serve as a biomarker of the mesenchymal subtype in patients with GBM. In addition, CXCR4 mediated the mitogen-activated protein kinase signaling pathway, which was identified specifically in patients with mesenchymal GBM. CXCR4 associated genes or pathways may be a ‘basket trial’ option for the management of melanoma, prostate cancer and mesenchymal GBM. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF